Alkermes (ALKS) Change in Acquisitions & Divestments (2010 - 2026)
Alkermes (ALKS) posted quarterly Change in Acquisitions & Divestments of $20.1 million for Q2 2026, down 75.38% year-over-year from $81.6 million in Q2 2025, and down 52.86% quarter-over-quarter from $42.6 million in Q1 2026.
Alkermes (ALKS) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $20.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Acquisitions & Divestments fell 75.38% year-over-year to $20.1 million; the TTM figure through Jun 2026 stood at $565.1 million (up 54.23% YoY), while the FY2025 annual figure was $697.5 million, up 124.79% from the prior year.
- Change in Acquisitions & Divestments retreated to $20.1 million in Q2 2026 per ALKS's latest filing, from $42.6 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $377.1 million in Q4 2025 and bottomed at $20.1 million in Q2 2026.
- Historically, Change in Acquisitions & Divestments has averaged $94.9 million across 5 years, with a median of $82.0 million in 2024.
- Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 341.06% — and 2026, when it slumped 75.38%.
- Alkermes' Change in Acquisitions & Divestments stood at $90.6 million in 2022, then declined by 29.85% to $63.6 million in 2023, then soared by 34.48% to $85.5 million in 2024, then surged by 341.06% to $377.1 million in 2025, then slumped by 94.67% to $20.1 million in 2026.
- Business Quant data shows ALKS's Change in Acquisitions & Divestments at $20.1 million in Q2 2026, $42.6 million in Q1 2026, and $377.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.09 Mn |
| Jun 30, 2026 | 20.09 Mn |
| Mar 31, 2026 | 42.61 Mn |
| Mar 31, 2026 | 42.61 Mn |
| Dec 31, 2025 | 377.11 Mn |
| Dec 31, 2025 | 377.11 Mn |
| Sep 30, 2025 | 125.31 Mn |
| Sep 30, 2025 | 125.31 Mn |
| Jun 30, 2025 | 81.59 Mn |
| Jun 30, 2025 | 81.59 Mn |
| Mar 31, 2025 | 113.49 Mn |
| Mar 31, 2025 | 113.49 Mn |
| Dec 31, 2024 | 85.50 Mn |
| Dec 31, 2024 | 85.50 Mn |
| Sep 30, 2024 | 85.84 Mn |
| Sep 30, 2024 | 85.84 Mn |
| Jun 30, 2024 | 56.46 Mn |
| Jun 30, 2024 | 56.46 Mn |
| Mar 31, 2024 | 82.49 Mn |
| Mar 31, 2024 | 82.49 Mn |